MENU
+Compare
PROK
Stock ticker: NASDAQ
AS OF
Jun 6, 04:59 PM (EDT)
Price
$0.98
Change
+$0.19 (+24.05%)
Capitalization
126.63M

PROK ProKidney Corp Forecast, Technical & Fundamental Analysis

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more

PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PROK with price predictions
Jun 05, 2025

PROK in +5.78% Uptrend, rising for three consecutive days on June 04, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PROK advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on PROK as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PROK just turned positive on June 03, 2025. Looking at past instances where PROK's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

PROK moved above its 50-day moving average on June 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for PROK moved out of overbought territory on April 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PROK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PROK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). PROK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (370.370) is also within normal values, averaging (263.647).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PROK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PROK is expected to report earnings to rise 17.77% to -15 cents per share on August 07

ProKidney Corp PROK Stock Earnings Reports
Q2'25
Est.
$-0.15
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.09
The last earnings report on May 12 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 613.31K shares outstanding, the current market capitalization sits at 126.63M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEDIF0.06N/A
+2.97%
Medipharm Labs Corporation
CABGY29.860.71
+2.44%
Carlsberg AS
RDEIY10.25-0.03
-0.29%
Redeia Corporacion SA
OLCLY21.84-0.34
-1.56%
Oriental Land Co., Ltd.
NWBO0.25-0.01
-5.19%
Northwest Biotherapeutics, Inc.

PROK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-0.25%
RXRX - PROK
47%
Loosely correlated
-7.13%
IMNM - PROK
42%
Loosely correlated
+1.16%
ACLX - PROK
41%
Loosely correlated
+1.18%
RNA - PROK
41%
Loosely correlated
+4.00%
BEAM - PROK
41%
Loosely correlated
-0.87%
More